Imaging

Photo

Article • Supplemental imaging

The next breast screening advancement: Contrast-enhanced mammography

With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for breast cancer, and in the recommendations the Council formally recognized the advantages of digital breast tomosynthesis (DBT). This landmark acknowledges the research on and benefits of DBT, advocating…

Photo

Article • Experts outline European infrastructure

AI in health imaging: computational power isn’t everything

What will the future structure for artificial intelligence in health imaging across Europe look like? While the algorithms show great promise in collecting, storing, analysing, and using data to advance healthcare, delegates to a session on the topic at ECR 2023 in Vienna, also heard that it was important for the use of AI to move from research and more toward practical applications for patients.…

Photo

Article • Impact of ICM packaging and delivery systems

Contrast media bottles: benefits of switching to multi-dose

Iodinated contrast media (ICM) enhance CT imaging, but its single-dose packaging is increasingly proving at odds with modern, more sustainable imaging practices. New award-winning research by a radiology resident and faculty members at Vanderbilt University Medical Center in Nashville, Tennessee, proposes a promising alternative: A switch from using single-dose injectable contrast media kits to…

Photo

Article • Digital breast tomosynthesis (DBT)

New EU recommendations for breast screening enhance opportunities for early detection

Mammography has been an essential imaging technology for breast cancer detection for decades. As the industry has continued to innovate, one advancement in mammography has particularly changed the landscape of breast imaging: digital breast tomosynthesis (DBT), also known as 3D mammography.

1395 show more articles
Subscribe to Newsletter